Avita raises $10m for ReCell rollout

Regenerative medicine company Avita Medical has raised $10 million from investors to support the commercialisation of its ReCell device, which is being trialled by a US government agency.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

Share Price

Closing price for the last 90 trading days
Source: Morningstar

Total Shareholder Return as at 28/02/18

1 year TSR5 year TSR
400thPura Vida Energy2%-41%
561stSuda Pharmaceuticals-21%-14%
572ndResource Development Group-23%-32%
602ndAdvanced Braking Technology-29%-22%
706thAvita Medical-45%-11%
711 WA (and selected non WA) listed companies ranked by 1 year TSR relative to other companies with similar revenue
Source: Morningstar

Share Transactions

$75k Bought
$10k Bought
$5k Bought
Total value as at the date of the transaction
Source: Morningstar


88th↑Pura Vida Energy$9.4m
89th↓Resource Development Group$9.3m
90th↑Avita Medical$8.0m
91st↓Advanced Braking Technology$7.7m
92nd↓Suda Pharmaceuticals$7.3m
236 listed industrial companies ranked by revenue.
Source: Morningstar

Remuneration from Avita Medical

235thTim Rooney$506k
350thAndrew Quick$366k
631stLorraine Glover$216k
Ranked by total remuneration from all listed WA companies

BNiQ Disclaimer